1. Home
  2. KSPI vs BBIO Comparison

KSPI vs BBIO Comparison

Compare KSPI & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KSPI
  • BBIO
  • Stock Information
  • Founded
  • KSPI 2008
  • BBIO 2015
  • Country
  • KSPI Kazakhstan
  • BBIO United States
  • Employees
  • KSPI N/A
  • BBIO N/A
  • Industry
  • KSPI
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KSPI
  • BBIO Health Care
  • Exchange
  • KSPI Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • KSPI 13.6B
  • BBIO 12.5B
  • IPO Year
  • KSPI 2024
  • BBIO 2019
  • Fundamental
  • Price
  • KSPI $74.50
  • BBIO $71.90
  • Analyst Decision
  • KSPI Buy
  • BBIO Strong Buy
  • Analyst Count
  • KSPI 2
  • BBIO 19
  • Target Price
  • KSPI $113.00
  • BBIO $74.79
  • AVG Volume (30 Days)
  • KSPI 565.6K
  • BBIO 2.4M
  • Earning Date
  • KSPI 11-10-2025
  • BBIO 10-29-2025
  • Dividend Yield
  • KSPI N/A
  • BBIO N/A
  • EPS Growth
  • KSPI 13.36
  • BBIO N/A
  • EPS
  • KSPI 10.48
  • BBIO N/A
  • Revenue
  • KSPI $6,665,289,776.00
  • BBIO $353,780,000.00
  • Revenue This Year
  • KSPI $37.63
  • BBIO $123.32
  • Revenue Next Year
  • KSPI $21.15
  • BBIO $73.46
  • P/E Ratio
  • KSPI $7.06
  • BBIO N/A
  • Revenue Growth
  • KSPI 54.22
  • BBIO 62.46
  • 52 Week Low
  • KSPI $70.61
  • BBIO $25.34
  • 52 Week High
  • KSPI $113.55
  • BBIO $72.26
  • Technical
  • Relative Strength Index (RSI)
  • KSPI 50.79
  • BBIO 71.58
  • Support Level
  • KSPI $70.63
  • BBIO $64.41
  • Resistance Level
  • KSPI $74.66
  • BBIO $67.71
  • Average True Range (ATR)
  • KSPI 2.15
  • BBIO 2.80
  • MACD
  • KSPI 0.32
  • BBIO 0.35
  • Stochastic Oscillator
  • KSPI 59.94
  • BBIO 95.73

About KSPI Joint Stock Company Kaspi.kz

Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform that connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: